Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on July 20, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Over The Counter (OTC) Rapid Antigen Test Manufacturing

Closed
ASPR072023Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

Department Of Health And Human Services → Aspr/daappo/orm HqView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

DC, USA

Set-Aside

NONE

Documents

(1)

RFI+for+OTC+Manufacturing.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseClosed
Posted

Sources Sought

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Aspr/daappo/orm Hq
Contacts1 person available
OfficeWashington, DC, 20515, USA
Organization / Agency
Department Of Health And Human Services → Aspr/daappo/orm Hq
View Agency Profile
Office AddressWashington, DC, 20515, USA
Contacts

Full Description

Show more
This is a Request for Information (RFI) only. As set forth in FAR 15.201(e), the purpose of an RFI is to obtain market information. This RFI requests information about current domestic manufacturing capacities for Over the Counter (OTC) rapid antigen SARS-CoV-2 tests within U.S. facilities. This RFI is not a request for competitive proposals: therefore, responses to this notice are not considered offers and cannot be accepted by the Government to form a binding contract. Companies that respond will not be paid for submitting information. The Government intends to utilize information gathered from this RFI for planning and market research purposes.

More opportunities from Department Of Health And Human Services → Aspr/daappo/orm Hq

Same awarding agency